Test and Treat Policy for HIV patients | PIB
The Government has launched the ‘Test and Treat Policy for HIV patients’ in April 2017. As per this policy all people living with HIV (PLHIV) are to be treated with Antiretro Viral Therapy regardless of CD4 count, clinical stage, age or population. The National Strategic Plan for HIV/AIDS and STI 2017-2024 has been approved in June 2017.
- Accelerating HIV prevention in key population and ‘at risk group’.
- Expanding quality assured HIV testing with universal access to comprehensive HIV care.
- Elimination of mother to child transmission of HIV and syphilis.
- Addressing the critical enablers in HIV programming.
- Restructuring the strategic information system to be efficient and patient-centric.
Facts and figures –
- As per HIV estimation 2015, India is estimated to have 21 lakhs people infected with HIV and 15.2 lakhs PLHIV know their HIV status through the strategy of scaling up of HIV counselling & testing services in 23,019 health facilities.
- A total of 536 Anti-retroviral Therapy (ART) centres are providing ART treatment across the country.
- The National Guidelines on HIV Counselling & Testing Services (revised in Dec 2016) include the HIV screening through trained ancillary health care provider in community based setting for priority population including High Risk Groups, TB suspect & patients, STI/RTI attendees, sexual partners/ spouses of PLHIV, prison inmates, pregnant women, adolescent age group etc.